课题基金 / 基金详情

Gene expression analysis of metastatic breast cancer in lymph nodes using residual OSNA sample

Gene expression analysis of metastatic breast cancer in lymph nodes using residual OSNA sample
使用残留 OSNA 样本对淋巴结转移性乳腺癌进行基因表达分析
批准号:
24659164
负责人:
UMEKITA Yoshihisa
金额:
$1.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012 至 --

项目摘要

项目成果

UMEKITA Yoshihisa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The one-step nucleic acid amplification (OSNA) assay is a rapid and reliable procedure for the detection of sentinel lymph node (SLN) metastases using molecular biological techniques during the operation of breast cancer. In the present study, we focused “maspin”, which is the poor prognostic factor of human breast cancer and its expression was not detected in normal lymph nodes. The used samples were OSNA;0 (5 samples), OSNA;1+ (34 samples) and OSNA;3+ (59 samples). After the extraction of total RNA from residual OSNA samples, cDNA was generated and quantitative Real-time RT-PCR analysis was performed using human maspin primer/probe set. Maspin mRNA expression was noted in 46 samples (49.5%) and was significantly frequent in OSNA 2+ (p
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidation of molecular mechanism of maspin associated with poor prognosis of patients with lung squamous cell carcinoma
  • 批准号:
    19K09304
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.75万
  • 财政年份:
    2019
  • 负责人:
    UMEKITA Yoshihisa
  • 依托单位:
The elucidation of molecular mechanism of maspin related with unfavorable prognosis of human breast cancer patients
  • 批准号:
    16K10458
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2016
  • 负责人:
    UMEKITA Yoshihisa
  • 依托单位:
Molecular pathological study of prognostic factor in node-negative breast cancer patients
  • 批准号:
    13670181
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.15万
  • 财政年份:
    2001
  • 负责人:
    UMEKITA Yoshihisa
  • 依托单位:
国内基金
海外基金
HP靶向及TCb化疗联合乳癌术后方在HER2阳性乳腺癌患者中的前瞻性研究
  • 批准号:
    2024QN036
  • 项目类别:
    省市级项目
  • 资助金额:
    4.0万元
  • 批准年份:
    2024
  • 负责人:
    吴鸣远
  • 依托单位:
circEMCN编码多肽EMCN-81激活STAT3/VEGF通路调控炎性乳癌血管生成促进恶性进展的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    林颖
  • 依托单位:
CTSK调控ACSs-乳腺癌细胞交互功能促进脂肪移植乳癌术后重建的机制研究